Cargando…
Reply: Comment on alemtuzumab and inclusion body myositis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859147/ https://www.ncbi.nlm.nih.gov/pubmed/19892769 http://dx.doi.org/10.1093/brain/awp276 |
| _version_ | 1782180484391895040 |
|---|---|
| author | Dalakas, Marinos C. Rakocevic, Goran Schmidt, Jens McElroy, Beverly Harris-Love, Michael O. Shrader, Joseph A. Levy, Ellen W. Dambrosia, James |
| author_facet | Dalakas, Marinos C. Rakocevic, Goran Schmidt, Jens McElroy, Beverly Harris-Love, Michael O. Shrader, Joseph A. Levy, Ellen W. Dambrosia, James |
| author_sort | Dalakas, Marinos C. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2859147 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28591472010-04-26 Reply: Comment on alemtuzumab and inclusion body myositis Dalakas, Marinos C. Rakocevic, Goran Schmidt, Jens McElroy, Beverly Harris-Love, Michael O. Shrader, Joseph A. Levy, Ellen W. Dambrosia, James Brain Letters to the Editor Oxford University Press 2010-05 2009-11-05 /pmc/articles/PMC2859147/ /pubmed/19892769 http://dx.doi.org/10.1093/brain/awp276 Text en © The Author(s) 2009. Published by Oxford University Press on behalf of Brain. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Dalakas, Marinos C. Rakocevic, Goran Schmidt, Jens McElroy, Beverly Harris-Love, Michael O. Shrader, Joseph A. Levy, Ellen W. Dambrosia, James Reply: Comment on alemtuzumab and inclusion body myositis |
| title | Reply: Comment on alemtuzumab and inclusion body myositis |
| title_full | Reply: Comment on alemtuzumab and inclusion body myositis |
| title_fullStr | Reply: Comment on alemtuzumab and inclusion body myositis |
| title_full_unstemmed | Reply: Comment on alemtuzumab and inclusion body myositis |
| title_short | Reply: Comment on alemtuzumab and inclusion body myositis |
| title_sort | reply: comment on alemtuzumab and inclusion body myositis |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859147/ https://www.ncbi.nlm.nih.gov/pubmed/19892769 http://dx.doi.org/10.1093/brain/awp276 |
| work_keys_str_mv | AT dalakasmarinosc replycommentonalemtuzumabandinclusionbodymyositis AT rakocevicgoran replycommentonalemtuzumabandinclusionbodymyositis AT schmidtjens replycommentonalemtuzumabandinclusionbodymyositis AT mcelroybeverly replycommentonalemtuzumabandinclusionbodymyositis AT harrislovemichaelo replycommentonalemtuzumabandinclusionbodymyositis AT shraderjosepha replycommentonalemtuzumabandinclusionbodymyositis AT levyellenw replycommentonalemtuzumabandinclusionbodymyositis AT dambrosiajames replycommentonalemtuzumabandinclusionbodymyositis |